Other OTC - Delayed Quote USD

Kinetics Medical Adv A (KRXAX)

30.64 +0.29 (+0.95%)
At close: December 29 at 8:00 PM EST

Top 10 Holdings (71.88% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 10.49%
BMY
Bristol-Myers Squibb Company 9.85%
ABBV
AbbVie Inc. 7.92%
PFE
Pfizer Inc. 7.74%
MRK
Merck & Co., Inc. 7.11%
JNJ
Johnson & Johnson 6.74%
NVS
Novartis AG 6.28%
BIIB
Biogen Inc. 5.91%
AMGN
Amgen Inc. 5.32%
AZN
AstraZeneca PLC 4.53%

Sector Weightings

SectorKRXAX
Healthcare   98.89%
Industrials   1.11%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 1.13%
Stocks 98.87%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average KRXAX Category Average
Price/Earnings 0.06 24.55
Price/Book 0.23 5.28
Price/Sales 0.27 2.06
Price/Cashflow 0.08 17.54
Median Market Cap 93,309.26 34,862.81
3 Year Earnings Growth 13.36 32.48

Bond Holdings

Performance & Risk

YTD Return 4.18%
5y Average Return 7.81%
Rank in Category (ytd) 5
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.53
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Kinetics
Net Assets 19.35M
YTD Return 4.18%
Yield 0.62%
Morningstar Rating
Inception Date Sep 30, 1999

Fund Summary

The fund is a non-diversified fund that invests all of its investable assets in the Medical Portfolio, a series of Kinetics Portfolios Trust. The Portfolio invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants, and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.

Related Tickers